Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 26:18:2593-2608.
doi: 10.2147/DDDT.S465960. eCollection 2024.

A Health Technology Assessment Based on Chinese Guideline: Active Vitamin D and Its Analogs in the Treatment of Osteoporosis

Siyong Huang  1 , Jiabao Li  1 , Xiao Hu  1 , Jisheng Chen  1
Affiliations

A Health Technology Assessment Based on Chinese Guideline: Active Vitamin D and Its Analogs in the Treatment of Osteoporosis

Siyong Huang et al. Drug Des Devel Ther. .

Abstract

Objective: To quantitatively assess all dosage forms of three active vitamin D and its analogs, namely, calcitriol, alfacalcidol, and eldecalcitol, to provide a basis for the selection of active vitamin D and its analogs in hospitals.

Methods: In this study, three active vitamin D and its analogs were evaluated by quantitative scoring in five dimensions, including pharmaceutical properties (28 points), efficacy (27 points), safety (25 points), economy (10 points), and other attributes (10 points).

Results: The final scores of quantitative assessment for the selection of alfacalcidol soft capsules, calcitriol soft capsules I, calcitriol soft capsules II, alfacalcidol tablets, alfacalcidol capsules, alfacalcidol oral drops, calcitriol injection, and eldecalcitol soft capsules were 73.17, 72.06, 71.52, 71.29, 69.62, 68.86, 65.60, 64.05 points.

Conclusion: Based on the scoring results, alfacalcidol soft capsules, calcitriol soft capsules I, calcitriol soft capsules II, alfacalcidol tablets can be entered into the medication list of medical institutions as strongly recommended drugs. This study offers guidance on selecting and using active vitamin D and its analogs in hospitals, with consideration for the patient's needs.

Keywords: active vitamin D; alfacalcidol; calcitriol; eldecalcitol; hospital health technology assessment; osteoporosis.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

None
Graphical abstract
See this image and copyright information in PMC

References

    1. WA P. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med. 1993;94(6):646–650. doi:10.1016/0002-9343(93)90218-e - DOI - PubMed
    1. Zhang H, Hu Y, Chen X, et al. Expert consensus on the bone repair strategy for osteoporotic fractures in China. Front Endocrinol. 2022;13:989648. doi:10.3389/fendo.2022.989648 - DOI - PMC - PubMed
    1. Xi X, Mehmood A, Niu P, et al. Association of X-linked TLR-7 gene polymorphism with the risk of knee osteoarthritis: a case-control study. Sci Rep. 2022;12(1):7243. doi:10.1038/s41598-022-11296-4 - DOI - PMC - PubMed
    1. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomized controlled trials. BMJ. 2009;339:b3692. doi:10.1136/bmj.b3692 - DOI - PMC - PubMed
    1. de Freitas PH, Hasegawa T, Takeda S, et al. Eldecalcitol, a second-generation vitamin D analog, drives bone mini modeling and reduces osteoclastic number in trabecular bone of ovariectomized rats. Bone. 2011;49(3):335–342. doi:10.1016/j.bone.2011.05.022 - DOI - PubMed

MeSH terms